🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

12 recruiting trials

for E Coli Infections

A Study on the Safety and Immune Response of a Urinary Tract Infection (UTI) Vaccine in Adults 18-64 Years of Age and Clinical Efficacy in Females 18-64 Years of Age NCT06702449Phase 1, Phase 28 sites📍 Lenexa📍 Secaucus📍 Rochester GlaxoSmithKline · Tests: Candidate UTI vaccine low dose formulation 1, Candidate UTI vaccine low dose formulation 2, Candidate UTI vaccine mediu… Study of E. Coli Isolates From Recurrent Urinary Tract Infections NCT05826067n/a1 site📍 Brussels Université Catholique de Louvain · Tests: collection of bacterial strains Gram-Negative Bloodstream Infection Oral Antibiotic Therapy Trial NCT06080698NA11 sites📍 San Francisco📍 Denver📍 Baltimore Johns Hopkins University · Tests: Intravenous Antibiotics, Oral Antibiotics Hyperhydration in Children With Shiga Toxin-Producing E. Coli Infection NCT05219110NA26 sites📍 Birmingham📍 Little Rock📍 La Jolla University of Calgary · Tests: Infusion of 200% maintenance fluids as balanced crystalloid IV solution, Oral fluids; infusion of up to 110% maintenanc… Study of the Ecological and Evolutionary Dynamics of Escherichia Coli in the Digestive Commensal Flora NCT05153824n/a2 sites📍 Paris📍 Paris Assistance Publique - Hôpitaux de Paris Bacterial Interference for Preventing Recurrent Urinary Tract Infection - New Ways of Treatment NCT04846803NA2 sites📍 Aarhus N📍 Odense C Odense University Hospital · Tests: ABU bladder lavage, Saline bladder lavage Bacteriophage Therapy in Spinal Cord Injury Patients With Bacteriuria NCT06559618Phase 12 sites📍 St Louis📍 Houston Barbara Trautner · Tests: Phage Therapy, Placebo A Study of LBP-EC01 in the Treatment of Acute Uncomplicated UTI Caused by Drug Resistant E. Coli (ELIMINATE Trial) NCT05488340Phase 217 sites📍 Fresno📍 Lancaster📍 Los Angeles Locus Biosciences · Tests: LBP-EC01 0.1 x IV dose, LBP-EC01 0.01x IV Dose, LBP-EC01 IV Infusion Dose, Placebo, LBP-EC01 Phase 1b/2a Randomized Double-blind Study to Investigate Safety Tolerability PK PD Preliminary Efficacy of Oral Administration of SNIPR001 in Patients With Hematologic Malignancy Scheduled for Allogeneic Hematopoietic Stem-Cell Transplant Receiving FQ Prophylaxis & Harboring FQR Ecoli Pre-Transplant NCT06938867Phase 1, Phase 210 sites📍 Duarte📍 San Francisco📍 Baltimore SNIPR Biome Aps. · Tests: SNIPR001 consists of genetically modified bacteriophages specifically targeting Escherichia coli, Placebo 10 mL NCCR AntiResist:: New Approaches to Combat Antibiotic-resistant Bacteria NCT05017766n/a1 site📍 Basel University Hospital, Basel, Switzerland · Tests: analysis of antimicrobial resistance Pivmecillinam as Oral Step-Down Treatment for Escherichia Coli Febrile Urinary Tract Infection Versus Standard of Care NCT07236944Phase 413 sites📍 Haukeland📍 Oslo📍 Borås Uppsala University · Tests: Pivmecillinam, Standard of Care (Investigator Choice) Cefotetan Therapy for Escherichia Coli Infections NCT07318584Phase 21 site📍 Portland Oregon Health and Science University · Tests: Cefotetan, Carbapenems, Beta Lactam Antibiotics
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy